- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02567812
Database of Pelvic Inflammatory Disease
April 1, 2019 updated by: Taejong Song, Kangbuk Samsung Hospital
Prospective Data Collection of Patients With Pelvic Inflammatory Disease
The aim of this prospective study is to collect data on in-patients with pelvic inflammatory disease(PID) at Kangbuk Samsung Hospital.
Study Overview
Status
Recruiting
Conditions
Detailed Description
The aim of this prospective study is to collect data on in-patients with pelvic inflammatory disease(PID) at Kangbuk Samsung Hospital.
If patients agree to participate in this clinical trial, patient's data (such as age, body mass index, preoperative findings, laboratory findings, radiologic findings, operative findings, pathologic findings, postoperative findings) will be collected in a research database.
The research database will be updated, every 6 month, to include data on patient's disease outcome and follow-up care.
Although most data will be collected form the medical record, patient may agin be contacted so that researchers can collection some data if it is not in the medical record.
Study Type
Observational
Enrollment (Anticipated)
200
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Taejong Song, MD PhD
- Phone Number: +82-10-4035-8405
- Email: taejong.song@gmail.com
Study Locations
-
-
-
Seoul, Korea, Republic of, 110-746
- Recruiting
- Kangbuk Samsung Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years to 80 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Probability Sample
Study Population
Pelvic inflammatory disease or pelvic inflammatory disorder (PID) is an infection of the upper part of the female reproductive system namely the uterus, fallopian tubes, or the ovaries.
Often there may be no symptoms.
Signs and symptoms, when present may include lower abdominal pain, vaginal discharge, fever, burning with urination, pain with sex, or irregular menstruation.
Untreated PID can result in long term complications including infertility, ectopic pregnancy, chronic pelvic pain, and cancer.
Description
Inclusion Criteria:
- All in-patient with PID who diagnosed at Kangbuk Samsung Hospital
Exclusion Criteria:
- Secondary PID caused by other surgical problem or disease
- An inability to fill-up the informed consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
In-patient with PID
In-patient with PID who diagnosed at Kangbuk Samsung Hospital
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
PID database
Time Frame: 10 years
|
number of participants with pelvic inflammatory disease
|
10 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2015
Primary Completion (Anticipated)
September 1, 2024
Study Completion (Anticipated)
September 1, 2024
Study Registration Dates
First Submitted
October 1, 2015
First Submitted That Met QC Criteria
October 2, 2015
First Posted (Estimate)
October 5, 2015
Study Record Updates
Last Update Posted (Actual)
April 3, 2019
Last Update Submitted That Met QC Criteria
April 1, 2019
Last Verified
April 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2015-04-009
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Inflammatory Pelvic Disease
-
Johns Hopkins UniversityNational Institute of Nursing Research (NINR)CompletedPelvic Inflammatory Disease (PID)United States
-
China Academy of Chinese Medical SciencesPeking University First Hospital; Peking Union Medical College Hospital; Chengdu... and other collaboratorsUnknown
-
China Academy of Chinese Medical SciencesPeking University First Hospital; Peking Union Medical College Hospital; Chengdu... and other collaboratorsUnknown
-
RAPbarcelonaCompletedChronic Pain | Pelvic Pain | Physical Therapy | Chronic Pain Syndrome | Pelvic Pain Syndrome | Chronic Pelvic Inflammatory DiseaseSpain
-
The University of Hong KongCompletedSexually Transmitted Infections | Induced Abortion | Postaboral Pelvic Inflammatory DiseaseChina
-
Children's Hospital of PhiladelphiaCompletedPelvic Inflammatory DiseaseUnited States
-
University of KarachiZhuzhou Qianjin Pharmaceutical Co., Ltd., 801, Zhuzhou, China; Center for bioequivalence...CompletedPelvic Inflammatory DiseasePakistan
-
Shanghai University of Traditional Chinese MedicineUnknown
-
BayerCompletedPelvic Inflammatory DiseaseGermany, Italy, France, Hungary, Sweden, Poland, South Africa, Russian Federation, Finland, Denmark, Lithuania, United Kingdom, Greece
-
PfizerCompletedPelvic Inflammatory DiseaseJapan